ACRO BIOMEDICAL CO., LTD. Research and Development in Process
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Research and Development in Process of $2.52 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-05-16
- ACRO BIOMEDICAL CO., LTD. research and development in process for the quarter ending 2022-03-31 was $2.52M.
- ACRO BIOMEDICAL CO., LTD. research and development in process for the quarter ending 2021-03-31 was $0.00.
- ACRO BIOMEDICAL CO., LTD. research and development in process for fiscal 2021 was $5.29M.
- ACRO BIOMEDICAL CO., LTD. research and development in process for fiscal 2020 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 12 month |
|---|---|---|
| 2022-03-31 | $2.52M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $5.29M 10-K · filed 2022-04-15 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $0.00 10-K · filed 2022-04-15 |